Your browser is no longer supported. Please, upgrade your browser.
Order: Signal: Tickers:
Overview Valuation Financial Ownership Performance Technical Custom Charts Tickers Quotes Basic TA News Snapshot
Total: 200 #1
TickerDRAM [NASD]
CompanyDataram Corporation
CountryUSA
IndustryData Storage Devices
Market Cap8.04MEPS (ttm)-1.58
P/E-EPS this Y50.00%
Forward P/E-EPS next Y-
PEG-EPS past 5Y9.30%
P/S0.27EPS next 5Y-
P/B14.67EPS Q/Q-250.00%
Dividend-Sales Q/Q-6.80%
Insider Own1.90%Inst Own1.90%
Insider Trans100.83%Inst Trans2.06%
Short Float1.11%EarningsMar 30/a
Analyst Recom-Target Price-
Avg Volume16.37K52W Range1.41 - 5.43
Feb-09-15 08:45AMDataram Chairman and Interim-CEO, David Moylan Acquires $100,000 of Common Shares Business Wire
Feb-06-15 05:24PMDATARAM CORP Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Tran EDGAR Online
Jan-28-15 08:45AMDataram Announces Cost-Cutting Measures Resulting in Approximately $2.2 Million in Annual Cash Savings Business Wire
Jan-23-15 07:59AMDATARAM CORP Files SEC form 8-K, Change in Directors or Principal Officers, Other Events EDGAR Online
Jan-22-15 07:00PMDataram Announces Appointment of Dave Moylan as Interim CEO Business Wire
Dec-30-14 01:04PMDATARAM CORP Financials EDGAR Online Financials
Dec-29-14 04:17PMDATARAM CORP Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online
Dec-29-14 04:15PMDataram Reports Fiscal 2015 Second Quarter and Year to Date Financial Results Business Wire
Dec-24-14 07:07PM10-Q for Dataram Corp. Company Spotlight
Dec-22-14 02:52PMDATARAM CORP Files SEC form 10-Q, Quarterly Report EDGAR Online
TickerTCON [NASD]
CompanyTRACON Pharmaceuticals, Inc.
CountryUSA
IndustryBiotechnology
Market Cap210.61MEPS (ttm)-0.56
P/E-EPS this Y-53.50%
Forward P/E-EPS next Y32.50%
PEG-EPS past 5Y0.00%
P/S81.00EPS next 5Y-
P/B-EPS Q/Q22.70%
Dividend-Sales Q/Q-
Insider Own20.60%Inst Own-
Insider Trans0.00%Inst Trans-
Short Float0.09%Earnings-
Analyst Recom1.30Target Price19.00
Avg Volume153.72K52W Range9.02 - 14.97
Mar-02-15Reiterated Oppenheimer Outperform $22 → $26
Mar-02-15Reiterated Stifel Buy $16 → $20
Mar-02-15 01:02AM1:02 am Tracon Pharmaceuticals announces positive Phase 1b results for TRC105 in combination with Inlyta Briefing.com
Feb-28-15 07:00AMTRACON Pharmaceuticals Announces Positive Phase 1b Results for TRC105 in Combination With Inlyta(R) (axitinib) at the American Society of Clinical Oncology (ASCO) 2015 Genitourinary Cancers Symposium GlobeNewswire
Feb-27-15 04:04PMTRACON PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and EDGAR Online
Feb-27-15 08:00AMTRACON Pharmaceuticals Appoints Stephen Worland to Its Board of Directors GlobeNewswire
Feb-24-15 07:07AMCoverage initiated on Tracon Pharmaceuticals by Oppenheimer and Stifel Briefing.com
Feb-19-15 12:59PMTRACON Pharmaceuticals Announces Upcoming Presentation of Results From a Clinical Trial of TRC105 in Patients With Renal Cell Carcinoma at the American Society of Clinical Oncology (ASCO) 2015 Genitourinary Cancers Symposium GlobeNewswire
Feb-04-15 04:05PMTRACON PHARMACEUTICALS, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Fin EDGAR Online
Feb-02-15 01:35PMLast Week's Biotech IPO Recap Benzinga
Jan-30-15 01:29PMSpark Therapeutics Ignites With Hot Biotech IPO at Investor's Business Daily
Jan-30-15 11:52AMIPO Roundup: Shake Shack Shares More Than Double Out of Gate at TheStreet
TickerWBAI [NYSE]
Company500.com Limited
CountryChina
IndustryGaming Activities
Market Cap352.20MEPS (ttm)0.70
P/E14.31EPS this Y7.70%
Forward P/E7.14EPS next Y25.38%
PEG0.91EPS past 5Y50.70%
P/S3.81EPS next 5Y15.75%
P/B1.96EPS Q/Q-87.20%
Dividend-Sales Q/Q51.90%
Insider Own15.07%Inst Own66.30%
Insider Trans0.00%Inst Trans45.87%
Short Float-EarningsFeb 20/b
Analyst Recom3.00Target Price14.00
Avg Volume1.01M52W Range9.20 - 54.00
Mar-02-15 04:00PMINVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in 500.com Limited (WBAI) to Contact the Firm Marketwired
Mar-02-15 12:44PM500.com (WBAI) Stock Rises Today Despite Another Sales Suspension Announcement at TheStreet
Mar-02-15 06:51AM500.com Limited Provides Additional Information on Temporary Suspension of Sales by Provincial Sports Lottery Administration Centers PR Newswire
Feb-27-15 11:01PM500.COM SHAREHOLDER ALERT: Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of 500.com Limited Business Wire
Feb-27-15 09:12PMEQUITY ALERT: The Rosen Law Firm Files Securities Fraud Class Action Against 500.com Limited Business Wire
Feb-26-15 10:44AM500.com (WBAI) Stock Recovers Today After Share Repurchase Program Announcement at TheStreet
Feb-26-15 07:53AM500.com Limited Announces Share Repurchase Program PR Newswire
Feb-25-15 09:32PMINVESTOR ALERT: Investigation on Behalf of Investors of 500.com Limited Announced by Law Offices of Howard G. Smith Business Wire
Feb-25-15 08:29PM500.com Sails Through Choppy Seas: Deutsche at Barrons.com
Feb-25-15 05:32PMINVESTOR ALERT: Investigation of 500.com Limited Announced by Glancy Binkow & Goldberg LLP Business Wire
TickerBIOC [NASD]
CompanyBiocept, Inc.
CountryUSA
IndustryMedical Laboratories & Research
Market Cap45.16MEPS (ttm)-4.32
P/E-EPS this Y28.90%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S589.60EPS next 5Y40.00%
P/B4.91EPS Q/Q25.00%
Dividend-Sales Q/Q-67.80%
Insider Own0.60%Inst Own2.70%
Insider Trans0.00%Inst Trans-16.42%
Short Float1.20%EarningsMar 09/a
Analyst Recom-Target Price-
Avg Volume2.30M52W Range1.09 - 9.70
Mar-02-15 06:08PMMost active Nasdaq-traded stocks AP
Mar-02-15 08:30AMDr. David Rimm Joins Biocept, Inc. as a Scientific Advisor GlobeNewswire
Feb-26-15 03:35PMHas Biocept Reached an Inflection Point? at 24/7 Wall St.
Feb-25-15 04:15PMBiocept, Inc. Schedules Webcast and Conference Call for Fourth Quarter 2014 Financial Results GlobeNewswire
Feb-23-15 01:35PMBiocept Breaks Through With Columbia Study at 24/7 Wall St.
Feb-23-15 08:30AMStudy Highlights Value of Biocept's Blood-Based Diagnostic for Determining Hormonal Status in Patients With Metastatic Breast Cancer GlobeNewswire
Feb-14-15 01:04PMBIOCEPT INC Financials EDGAR Online Financials
Feb-10-15 01:21PMBiocept (BIOC) Stock Plummets Today After Pricing Public Offering, Warrants at TheStreet
Feb-09-15 06:21PMBiocept, Inc. Prices $10,000,000 Public Offering GlobeNewswire
Jan-20-15 08:30AMBiocept Introduces New Test for Patients With Non-Small Cell Lung Cancer GlobeNewswire
TickerDQ [NYSE]
CompanyDaqo New Energy Corp.
CountryChina
IndustrySemiconductor Equipment & Materials
Market Cap294.49MEPS (ttm)0.73
P/E38.49EPS this Y34.50%
Forward P/E5.85EPS next Y81.83%
PEG-EPS past 5Y-31.30%
P/S1.73EPS next 5Y-
P/B0.95EPS Q/Q157.00%
Dividend-Sales Q/Q59.80%
Insider Own5.33%Inst Own29.90%
Insider Trans0.00%Inst Trans35.56%
Short Float4.02%EarningsMar 19/b
Analyst Recom1.50Target Price65.00
Avg Volume103.74K52W Range17.70 - 56.98
Feb-26-15 09:34AM10 Nasdaq tech stocks expected to rise as much as 189% at MarketWatch
Feb-23-15 04:30PMCan Century Aluminum (CENX) Surprise This Earnings Season? - Analyst Blog Zacks
Feb-23-15 12:26PMSigma-Aldrich (SIAL) Strikes New 52-Week High - Analyst Blog Zacks
Feb-20-15 01:00PMWill U.S. Silica (SLCA) Surprise This Earnings Season? - Analyst Blog Zacks
Feb-20-15 11:50AMWill Allied Nevada Gold (ANV) Turn It Around This Earnings? - Analyst Blog Zacks
Feb-18-15 11:00AMCan Gibraltar (ROCK) Surprise Q4 Earnings amid Adversities? - Analyst Blog Zacks
Feb-17-15 03:40PMCan MRC Global Surprise Q4 Earnings Amid Adversities? - Analyst Blog Zacks
Feb-17-15 03:30PMWill CVR Partners (UAN) Surprise This Earnings Season? - Analyst Blog Zacks
Feb-13-15 10:08AMSigma-Aldrich Q4 Earnings Top on Organic Sales Gain - Analyst Blog Zacks
Feb-12-15 02:00PMInternational Flavors & Fragrances Beats on Q4 Earnings - Analyst Blog Zacks
TickerMEIL [NASD]
CompanyMethes Energies International Ltd.
CountryUSA
IndustryChemicals - Major Diversified
Market Cap19.29MEPS (ttm)-0.67
P/E-EPS this Y-22.40%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S2.47EPS next 5Y-
P/B3.65EPS Q/Q5.30%
Dividend-Sales Q/Q41.20%
Insider Own19.53%Inst Own2.40%
Insider Trans0.00%Inst Trans-5.49%
Short Float0.33%Earnings-
Analyst Recom-Target Price-
Avg Volume53.55K52W Range0.63 - 4.35
Jan-23-15 12:22PMMETHES ENERGIES INTERNATIONAL LTD Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statement EDGAR Online
Jan-20-15 09:00AMMethes Energies to Receive $4 Million for a Limited License of Its Technology Accesswire
Dec-22-14 09:00AMMethes Energies Welcomes the Re-Instatement of the Biodiesel Tax Incentive Also Known as the Blenders Tax Credit Accesswire
Nov-06-14 11:47AMMETHES ENERGIES INTERNATIONAL LTD Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
Oct-22-14 01:04PMMETHES ENERGIES INTERNATIONAL LTD Financials EDGAR Online Financials
Oct-17-14 09:00AMMethes Energies Provides Business and Industry Update Marketwired
Oct-15-14 04:01PMMETHES ENERGIES INTERNATIONAL LTD Files SEC form 10-Q, Quarterly Report EDGAR Online
Sep-16-14 09:00AMMethes Energies Attracts Large Response to Recent Successful Webinar Marketwired
Sep-10-14 09:00AMMethes Energies Achieves Record Biodiesel Production in August 2014 and Its Third Quarter Marketwired
Sep-05-14 09:00AMMethes Energies Has Attained the QAP-B RIN Assurance Status Marketwired
TickerTCPI [NYSE]
CompanyTCP International Holdings Ltd.
CountryChina
IndustryDiversified Electronics
Market Cap75.07MEPS (ttm)0.34
P/E7.97EPS this Y236.40%
Forward P/E3.07EPS next Y36.90%
PEG-EPS past 5Y0.00%
P/S0.17EPS next 5Y-
P/B0.91EPS Q/Q6.70%
Dividend-Sales Q/Q8.80%
Insider Own43.30%Inst Own24.00%
Insider Trans0.54%Inst Trans12.39%
Short Float30.25%Earnings-
Analyst Recom1.80Target Price17.50
Avg Volume102.04K52W Range2.60 - 11.40
Mar-02-15 05:33PMEQUITY ALERT: The Rosen Law Firm Files Securities Class Action Against TCP International Holdings Ltd. Business Wire
Mar-02-15 10:02AMINVESTOR ALERT: Investigation of TCP International Holdings Ltd. Announced by Glancy Binkow & Goldberg LLP Business Wire
Mar-02-15 07:33AM7:33 am TCP International issues statement on recent litigation; co has voluntarily chosen to conduct additional levels of quality control on its products Briefing.com
Mar-02-15 07:30AMTCP Issues Statement on Recent Litigation PR Newswire
Feb-27-15 10:00PMTCPI INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates TCP International Holdings Ltd. Following Allegations of Violations of Federal Law Business Wire
Feb-27-15 09:41PMHarwood Feffer LLP Announces Investigation of TCP International Holdings Ltd. PR Newswire
Feb-27-15 09:32PMINVESTOR ALERT: Investigation on Behalf of Investors of TCP International Holdings Ltd. Announced by Law Offices of Howard G. Smith Business Wire
Feb-27-15 07:30PMRyan & Maniskas, LLP Announces Investigation of TCP International Holdings Ltd. PR Newswire
Feb-27-15 05:10PMTCPI SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Violations of Securities Laws by TCP International Holdings Ltd. Business Wire
Feb-27-15 03:51PMSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of TCP International Holdings Ltd. - TCPI PR Newswire
TickerCYCC [NASD]
CompanyCyclacel Pharmaceuticals, Inc.
CountryUSA
IndustryBiotechnology
Market Cap38.87MEPS (ttm)-0.88
P/E-EPS this Y26.30%
Forward P/E-EPS next Y4.20%
PEG-EPS past 5Y38.20%
P/S21.59EPS next 5Y-
P/B1.56EPS Q/Q31.30%
Dividend-Sales Q/Q133.30%
Insider Own7.47%Inst Own7.90%
Insider Trans0.18%Inst Trans-4.47%
Short Float3.79%EarningsMar 24/a
Analyst Recom3.00Target Price9.00
Avg Volume728.67K52W Range0.51 - 4.14
Mar-02-15 08:35AMClinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels PR Newswire
Mar-02-15 06:09PMNasdaq stocks posting largest volume increases AP
Mar-02-15 06:08PMMost active Nasdaq-traded stocks AP
Feb-20-15 05:12PMCYCLACEL PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events EDGAR Online
Feb-06-15 04:22PMCYCLACEL PHARMACEUTICALS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule EDGAR Online
Feb-03-15 07:00AMCyclacel Pharmaceuticals to Present at the 17th Annual BIO CEO & Investor Conference GlobeNewswire
Jan-06-15 07:00AMCyclacel Pharmaceuticals to Present at the Biotech Showcase(TM) 2015 Conference GlobeNewswire
Dec-16-14 08:17AMCYCLACEL PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
Dec-16-14 07:00AMCyclacel Announces Enrollment of 486 Patients, DSMB Recommendations and That the Seamless Phase 3 Trial of Sapacitabine in AML Will Continue to Final Analysis GlobeNewswire
Dec-04-14 04:28PMCYCLACEL PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events EDGAR Online
TickerOHRP [NASD]
CompanyOhr Pharmaceutical, Inc.
CountryUSA
IndustryBiotechnology
Market Cap284.50MEPS (ttm)-0.49
P/E-EPS this Y-36.70%
Forward P/E-EPS next Y-37.40%
PEG-EPS past 5Y-32.60%
P/S-EPS next 5Y-
P/B10.99EPS Q/Q-80.00%
Dividend-Sales Q/Q-
Insider Own1.90%Inst Own21.00%
Insider Trans8.44%Inst Trans1.77%
Short Float9.00%Earnings-
Analyst Recom1.70Target Price28.00
Avg Volume151.58K52W Range6.01 - 20.00
Mar-02-15 04:31PMOHR PHARMACEUTICAL INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
Mar-02-15 07:31AM7:31 am Ohr Pharmaceutical announces additional positive anatomic data from the OHR-102 IMPACT study interim analysis; rapid resolution in SHRM correlates with early improvements in visual acuity observed in phase II IMPACT study in wet AMD Briefing.com
Mar-02-15 07:30AMOhr Pharmaceutical Announces Additional Positive Anatomic Data From the OHR-102 IMPACT Study Interim Analysis Presented at Annual Macula Society Meeting GlobeNewswire
Feb-26-15 04:30PMOHR PHARMACEUTICAL INC Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial Stateme EDGAR Online
Feb-26-15 08:00AMOhr Pharmaceutical Appoints Avner Ingerman, M.D. as Chief Clinical Officer GlobeNewswire
Feb-26-15 05:54AMCoverage initiated on Ohr Pharma by ROTH Capital Briefing.com
Feb-14-15 01:04PMOHR PHARMACEUTICAL INC Financials EDGAR Online Financials
Feb-12-15 07:07PM10-Q/A for Ohr Pharmaceutical, Inc. Company Spotlight
Feb-11-15 04:57PMOHR PHARMACEUTICAL INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
Feb-11-15 12:54PMOhr Pharmaceutical Announces Closing of Public Offering of Common Stock GlobeNewswire
TickerNKA [NYSE]
CompanyNiska Gas Storage Partners LLC
CountryUSA
IndustryOil & Gas Pipelines
Market Cap71.06MEPS (ttm)-8.02
P/E-EPS this Y60.30%
Forward P/E-EPS next Y88.60%
PEG-EPS past 5Y-15.70%
P/S0.37EPS next 5Y1.00%
P/B0.31EPS Q/Q-
Dividend-Sales Q/Q51.90%
Insider Own0.10%Inst Own63.60%
Insider Trans0.00%Inst Trans2.35%
Short Float2.49%EarningsFeb 02/b
Analyst Recom3.90Target Price2.33
Avg Volume485.66K52W Range1.44 - 14.78
Feb-10-15 01:04PMNISKA GAS STORAGE PARTNERS LLC Financials EDGAR Online Financials
Feb-05-15 07:07PM10-Q for Niska Gas Storage Partners LLC Company Spotlight
Feb-03-15 02:57PMNISKA GAS STORAGE PARTNERS LLC Files SEC form 10-Q, Quarterly Report EDGAR Online
Feb-02-15 04:55PMNiska Gas Storage Canada ULC -- Moody's downgrades Niska's CFR to Caa1; Negative Outlook at Moody's
Feb-02-15 09:00AMNiska Gas Storage Partners LLC Earnings Call scheduled for 9:00 am ET today CCBN
Feb-02-15 07:47AMNiska Gas Storage Partners LLC Announces Suspension of Common Unit Distribution and Third Quarter Results for Fiscal 2015 Thomson Reuters ONE
Feb-02-15 07:45AMNISKA GAS STORAGE PARTNERS LLC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statement EDGAR Online
Feb-02-15 07:07AMQ3 2015 Niska Gas Storage Partners LLC Earnings Release - Before Market Open CCBN
Jan-23-15 04:17PMNiska Gas Storage Partners LLC Announces Timing of Fiscal 2015 Third Quarter Earnings Thomson Reuters ONE
Jan-07-15 02:16PMNISKA GAS STORAGE PARTNERS LLC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
1 2 3 4 5 6 ... 10 ... 20 next